Steven K. Grinspoon, MD, is Professor of Medicine at Harvard Medical School, Director of the MGH Program in Nutritional Metabolism, and Co-Director of the Nutrition Obesity Research Center at Harvard. Dr. Grinspoon earned his medical degree from the University of Rochester. He then completed his Internal Medicine Residency and Chief Resident year at Columbia Presbyterian Hospital/Columbia University and his Endocrinology Fellowship at Massachusetts General Hospital/Harvard University.

Dr. Grinspoon's research career has been focused on mechanisms of metabolic and cardiovascular complications in HIV. He has led NIH RO1-funded studies investigating HIV-infected patients for over 20 years and has numerous peer-reviewed publications. Work from his lab has suggested an increased rate of myocardial infarction (heart attacks) in HIV-infected patients and highlighted the relative contributions of traditional and non-traditional risk factors. Additionally, his work on strategies to improve insulin resistance and visceral fat accumulation among HIV-infected patients led to the first FDA-approved therapy for lipodystrophy. Dr. Grinspoon is a member of the American Society for Clinical Investigation and the Association of American Physicians and received the 2014 Edward H. Ahrens Award for his outstanding contributions to Translational Science and Patient Oriented research from the Association of Clinical and Translational Sciences. He has also chaired the American Heart Association State of the Science Conference on Cardiovascular Disease in HIV-infected patients.

Dr. Grinspoon is the Co-Principal Investigator of the Clinical Coordinating Center for REPRIEVE, Chair of the REPRIEVE protocol, and Chair of the Operational Leadership Committee.